Recent Finacing
Recent Raise
Cytovation is a clinical-stage immuno-oncology spin-off developing CyPep-1, a tumor-selective membrane-targeting peptide that forms pores, lyses cancer cells, and elicits in situ anti-tumor immune responses.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Cytovation.
